Short Communication
Benjamin LONGO MBENZA
Abstract
Background: Five P Medicine (Predictive, Personalized, Preventive, Participating, and Precise, Evidence-Based) for the Management of NAFDL, NASH, Fibrosis, Compensated Cirrhosis, Liver Cancer, HCC Risk and Prognosis, is well established in Rich Western Countries. However, Innovations and Artificial Intelligence such as Glycomics, Genomics, Molecular biology are lacking in Democratic Republic of the Congo (DRC). Abstract: Thus, this lecture of the Art reports the natural history, the pathogenesis, and the prognostic value of Metabolic Hepatic Steatosis (NAFDL and NASH) for Subclinical Hypothyroidism with Insulin Resistances, Metabolic Syndrome, Ischemic Atherosclerosis, Type 2 Diabetes Mellitus, and HCC Complex Liver diseases (CLD) among Central Africans in Kinshasa from 2000 to 2018.